Jay Parrish, Ph.D., is the Chief Business Officer at Vir. Previously he worked at Gilead Sciences, Inc. on the Corporate Development team, where he was involved in building Gilead’s oncology and infectious disease portfolio, ultimately leading infectious disease business development for the company. In the Corporate Development role, Dr. Parrish gained significant experience with search and evaluation, negotiations and transactions including in-licensing, out-licensing and M&A deals.
Jay Parrish, Ph.D., is the Chief Business Officer at Vir. Previously he worked at Gilead Sciences, Inc. on the Corporate Development team, where he was involved in building Gilead’s oncology and infectious disease portfolio, ultimately leading infectious disease business development for the company. In the Corporate Development role, Dr. Parrish gained significant experience with search and evaluation, negotiations and transactions including in-licensing, out-licensing and M&A deals.